亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Compositions and Methods for Activating Toll-Like Receptors

详细技术说明
The present invention relates to compositions of a member of the cholesterol-dependent cytolysin (CDC) family and methods of using these compositions to activate toll-like receptor 4 and to identify modulators of toll-like receptor 4 activation. Activation of toll-like receptor 4 by endotoxin or lipopolysaccharide (LPS) can lead to septic shock or septicemia. Compounds identified as modulators, and more particularly inhibitors, of toll-like receptor 4 activation by a member of the CDC family are expected to be useful in the treatment of septic shock and/or septicemia. It is believed that isolated CDCs, fragments, or mimetics may inhibit the interaction of toll-like receptor 4 and endotoxin or LPS.
*Abstract
None
*IP Issue Date
Apr 21, 2009
*Principal Investigation

Name: Michael Karin

Department:


Name: Jin Mo Park

Department:


Name: Richard Rest

Department:

附加资料
Patent Number: US7521073B2
Application Number: US2007764469A
Inventor: Rest, Richard | Karin, Michael | Park, Jin Mo
Priority Date: 12 Oct 2004
Priority Number: US7521073B2
Application Date: 18 Jun 2007
Publication Date: 21 Apr 2009
IPC Current: A61K003500 | A61P003100 | C12N000500
US Class: 424780 | 4350078 | 435170 | 435375
Assignee Applicant: Philadelphia Health and Education Corporation,Philadelphia,PA
Title: Compositions and methods for activating Toll-like receptor 4
Usefulness: Compositions and methods for activating Toll-like receptor 4
Summary: For treating septicemia or septic shock in subject; activating Toll-like receptor 4 (TLR4); inhibiting binding and/or interaction of TLR4 with endotoxin; and identifying modulator of TLR4 activation (claimed).
Novelty: Composition useful for treatment of septicemia or septic shock comprises an agent that inhibits activation of Toll-like receptor 4 by cholesterol-dependent cytolysin
主要类别
生物医学
细分类别
医药成分
申请号码
7521073
其他

State Of Development

A patent has issued for this invention, see 20070248706.


Related Materials

Park JM, Ng VH, Maeda S, Rest RF, Karin M. (2004) Anthrolysin O and Other Gram-Positive Cytolysins Are Toll-Like Receptor 4 Agonists. J Exp Med; 200(12):1647-55.


Tech ID/UC Case

19207/2009-057-0


Related Cases

2009-057-0

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备